CorVel Corp.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US2210061097
USD
70.36
-1.6 (-2.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About CorVel Corp. stock-summary
stock-summary
CorVel Corp.
Capital Markets
CorVel Corporation (Corvel) is a provider of workers' compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company's network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company's patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.
Company Coordinates stock-summary
Company Details
2010 Main St Ste 1020 , IRVINE CA : 92614-7206
stock-summary
Tel: 1 949 8511473
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 52 Schemes (23.04%)

Foreign Institutions

Held by 103 Foreign Institutions (3.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. V. Gordon Clemons
Chairman of the Board
Mr. R. Judd Jessup
Lead Independent Director
Mr. Steven Hamerslag
Independent Director
Mr. Alan Hoops
Independent Director
Ms. Jean Macino
Independent Director
Mr. Jeffrey Michael
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
235 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 7,973 Million (Small Cap)

stock-summary
P/E

102.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

29.43%

stock-summary
Price to Book

23.28